Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
As of May 2026, retatrutide doesnt have a UK marketing authorisation, which means no UK pharmacy or licensed clinic can legally dispense it
Meta-analyses show significant improvements in depression rating scales
Chosen by 80 000 customers worldwide, were one of the fastest growing peptide companies in the UK
The results of the threshold analysis revealed that, under the base-case assumptions, GLP-1 RAs would be cost-effective at an annual cost of AU$450 in the total population and AU$500 in the secondary prevention population
US$ 23.46
US$ 21.53
US$ 29.20
